COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN COMPARED TO WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN A MEDICARE POPULATION

被引：0
|
作者：
Ward, M. A. [1 ]
Biddle, A. K. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.657
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A121 / A121
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF EDOXABAN, APIXABAN, RIVAROXABAN AND DABIGATRAN VERSUS WARFARIN FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
    Marchetti, M.
    Liberato, N. L.
    Rognoni, C.
    Quaglini, S.
    HAEMATOLOGICA, 2014, 99 : 487 - 487
  • [22] ESTIMATING THE COST-EFFECTIVENESS OF LEFT ATRIAL APENDAGE CLOSURE COMPARED TO WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
    Shih, V
    Devine, B.
    VALUE IN HEALTH, 2015, 18 (03) : A46 - A46
  • [23] COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO WARFARIN FOR STROKE PROPHYLAXIS IN ATRIAL FIBRILLATION
    Lee, Soyon
    Anglade, Moise
    Pisacane, Robyn
    Pham, Dan
    Kluger, Jeffrey
    Coleman, Craig
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E600 - E600
  • [24] Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
    Carla Rognoni
    Monia Marchetti
    Silvana Quaglini
    Nicola Lucio Liberato
    Clinical Drug Investigation, 2014, 34 : 9 - 17
  • [25] Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
    Rognoni, Carla
    Marchetti, Monia
    Quaglini, Silvana
    Liberato, Nicola Lucio
    CLINICAL DRUG INVESTIGATION, 2014, 34 (01) : 9 - 17
  • [26] COST-EFFECTIVENESS OF DABIGATRAN COMPARED TO GENOTYPE-GUIDED WARFARIN DOSING FOR STROKE PROPHYLAXIS IN ATRIAL FIBRILLATION PATIENTS
    Lim, K. J.
    Tan, D. S. Y.
    Wee, H. L.
    VALUE IN HEALTH, 2012, 15 (07) : A602 - A602
  • [27] Cost-effectiveness of Dabigatran Compared With Rivaroxaban for Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in China
    Dong, Shu-Jie
    Wu, Bin
    Zhai, Suo-Di
    Zhang, Yan-Jun
    Chu, Yun-Bo
    Gupta, Parul
    Li, Ya-Huei
    CLINICAL THERAPEUTICS, 2020, 42 (01) : 144 - 156
  • [28] Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation-A Real Patient Data Analysis in a Hong Kong Teaching Hospital
    Chang, Andy M.
    Ho, Jason C. S.
    Yan, Bryan P.
    Yu, Cheuk Man
    Lam, Yat Yin
    Lee, Vivian W. Y.
    CLINICAL CARDIOLOGY, 2013, 36 (05) : 280 - 285
  • [29] Cost-effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
    Shah, Shimoli V.
    Gage, Brian F.
    CIRCULATION, 2010, 122 (21)
  • [30] Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
    Shah, Shimoli V.
    Gage, Brian F.
    CIRCULATION, 2011, 123 (22) : 2562 - 2570
12345